Shree Ganesh Remedies Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹21.11 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 30.38 per cent from ₹30.32 crore. This corresponds to a year-on-year *(YoY) decline of 21.96 per cent.
Operating Profit
Operating Profit stands at ₹6.73 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 30.04 per cent from ₹9.62 crore. This corresponds to a year-on-year *(YoY) decline of 32.02 per cent.
PBDT
PBDT stands at ₹6.65 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 28.57 per cent from ₹9.31 crore. This corresponds to a year-on-year *(YoY) decline of 34.93 per cent.
Profit Before Tax
Profit Before Tax stands at ₹3.98 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 40.77 per cent from ₹6.72 crore. This corresponds to a year-on-year *(YoY) decline of 47.07 per cent.
Net Profit
Net Profit stands at ₹3.09 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 37.70 per cent from ₹4.96 crore. This represents a 42.99 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Shree Ganesh Remedies Ltd Earnings
- YOY
- QOQ
Shree Ganesh Remedies Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Shree Ganesh Remedies Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Shree Ganesh Remedies Ltd Financial Reports
Shree Ganesh Remedies Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Shree Ganesh Rem | -0.32% | -5.03% | 1.48% | 0.10% | 6.35% | -30.32% |
| Anuh Pharma | -0.01% | -4.34% | 0.12% | -0.64% | -0.11% | -10.21% |
| Sigachi Indust. | -1.41% | -4.59% | -9.72% | -6.00% | -40.19% | -52.28% |
| Kopran | 3.45% | -4.28% | -0.68% | 15.47% | 13.90% | -17.58% |
| Zim Laboratories | -0.46% | 1.86% | 37.91% | 46.66% | 41.96% | 14.40% |
| Kilitch Drugs | 4.98% | -2.71% | 20.09% | -3.23% | -13.02% | -24.23% |
| Jenburkt Pharma | 1.73% | 1.21% | 16.45% | 11.54% | -7.41% | 12.12% |
Company Info
Company Information
Chairman / Executive Director / Managing Director : Chandubhai Kothia
Executive Director / Whole Time Director / CFO : Parth Chandulal Kothia
E D & Wholetime Director : Gunjan Chandulal Kothia
Independent Non Exe. Director : Maulikkumar Sudani
Independent Non Exe. Director : Parul Sahani
Independent Non Exe. Director : Shruti Rajesh Sohane
Company Sec. & Compli. Officer : Aditya Patel